Velsera

Velsera is a newly formed, revenue-generating technology and services company created through the merger of Seven Bridges, Pierian, and UgenTec. It operates at the intersection of diagnostics, genomics, and AI/ML, offering a comprehensive suite of platforms including the Seven Bridges bioinformatics environment, the Clinical Genomics Workspace (CGW), and the ARIA data harmonization platform. The company serves a substantial customer base, including 7 of the top 10 pharmas and over 80 clinical NGS labs, positioning itself as a key enabler for the entire precision medicine value chain from research to clinical diagnostics. Its business model combines software-as-a-service (SaaS) with high-value professional and scientific services.

Integrated suite of AI-enhanced software platforms for precision medicine, including Seven Bridges (bioinformatics TRE), Clinical Genomics Workspace (tertiary analysis/reporting), GRAF (graph reference genome), ARIA (data harmonization), and an IVD-grade Knowledgebase.

Velsera competes in a fragmented but crowded market. It faces competition from large cloud infrastructure providers (AWS, GCP, Azure) offering basic bioinformatics services, specialized clinical genomics software companies (e.g., Sophia Genetics, Fabric Genomics, QIAGEN), and in-house solutions developed by large pharma and diagnostic labs. Its differentiated full-stack, combined software-and-services model is its key competitive edge.